bevantolol and Coronary Heart Disease

bevantolol has been researched along with Coronary Heart Disease in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (85.71)	18.7374
1990's	1 (14.29)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abiko, Y; Ichihara, K; Miura, I; Nasa, Y	1
Abiko, Y; Hino, T; Ichihara, K; Sakai, K	1
Van Bremen, RH; Van der Giessen, WJ; Verdouw, PD; Verkeste, CM	1
Kaplan, HR	1
Hartog, JM; Verdouw, PD	1
Hartog, JM; Hugenholtz, PG; Saxena, PR; Verdouw, PD	1
Algarra, FJ; Bordes, P; Estruch, G; Ferrer, J; Gimeno, JV; Mainer, V; Olague, J; Serra, J	1

Trials

1 trial(s) available for bevantolol and Coronary Heart Disease

Article	Year
Acute, short- and long-term efficacy of oral bevantolol in patients with coronary artery disease: a placebo-controlled, randomized, double-blind study. Clinical cardiology, 1986, Volume: 9, Issue:9 Topics: Administration, Oral; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Forced Expiratory Volume; Heart Rate; Humans; Lung; Male; Middle Aged; Physical Exertion; Propanolamines; Propranolol; Random Allocation; Vital Capacity	1986

Article

Year

Acute, short- and long-term efficacy of oral bevantolol in patients with coronary artery disease: a placebo-controlled, randomized, double-blind study.

Clinical cardiology, 1986, Volume: 9, Issue:9

Topics: Administration, Oral; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Forced Expiratory Volume; Heart Rate; Humans; Lung; Male; Middle Aged; Physical Exertion; Propanolamines; Propranolol; Random Allocation; Vital Capacity

1986

Other Studies

6 other study(ies) available for bevantolol and Coronary Heart Disease

Article	Year
The inhibitory effect of bevantolol on the accumulation of non-esterified fatty acids during ischaemia in the dog heart in situ. Clinical and experimental pharmacology & physiology, 1991, Volume: 18, Issue:4 Topics: Adrenergic beta-Antagonists; Animals; Coronary Disease; Dogs; Electrocardiography; Fatty Acids, Nonesterified; Female; Heart; Heart Rate; Male; Myocardium; Propanolamines	1991
Attenuation of ischaemia-induced regional myocardial acidosis by bevantolol, a beta 1-adrenoceptor antagonist, in dogs. Pharmacology & toxicology, 1989, Volume: 64, Issue:4 Topics: Acidosis; Adrenergic beta-Antagonists; Animals; Blood Pressure; Coronary Disease; Coronary Vessels; Dogs; Female; Heart Rate; Hydrogen-Ion Concentration; Male; Myocardium; Propanolamines; Propranolol	1989
Antiarrhythmic action and protection of ischaemia myocardium after beta-blockade with bevantolol. European journal of pharmacology, 1985, May-20, Volume: 111, Issue:3 Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Coronary Disease; Hemodynamics; Propanolamines; Swine; Ventricular Fibrillation	1985
Bevantolol hydrochloride--preclinical pharmacologic profile. Angiology, 1986, Volume: 37, Issue:3 Pt 2 Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Coronary Disease; Heart; Organ Specificity; Propanolamines; Receptors, Adrenergic, alpha; Structure-Activity Relationship; Sympathomimetics	1986
Alleviation of myocardial ischaemia after administration of the cardioselective beta adrenoceptor antagonist bevantolol. Cardiovascular research, 1986, Volume: 20, Issue:4 Topics: Adrenergic beta-Antagonists; Animals; Coronary Disease; Disease Models, Animal; Drug Evaluation; Heart; Hemodynamics; Propanolamines; Swine	1986
Systemic and regional hemodynamic, antiarrhythmic and antiischemic effects of bevantolol in anesthetized pigs. The American journal of cardiology, 1986, Nov-26, Volume: 58, Issue:12 Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Cardiac Output; Coronary Disease; Hemodynamics; Myocardial Contraction; Propanolamines; Regional Blood Flow; Swine; Ventricular Fibrillation	1986